Rui Liu

Rui Liu is an Assistant Research Professor in the Department of Chemistry and Biochemistry at the University of Notre Dame, College of Science. His research is centered on medicinal chemistry and the development of novel antibiotics targeting drug-resistant bacterial pathogens.

Research Interests:
Dr. Liu's work focuses on designing new synthetic methodologies for drug discovery, particularly against infectious diseases caused by viruses, bacteria, and parasites. A major emphasis is on developing agents effective against Mycobacterium tuberculosis (Mtb) and nontuberculous mycobacteria (NTM). He pioneers the use of siderophore-drug conjugates (sideromycins) that exploit bacterial iron sequestration mechanisms to selectively target Gram-positive and Gram-negative bacteria, especially those listed by the WHO as critical priority multidrug-resistant pathogens. His research integrates synthetic organic chemistry with microbiological evaluation to create next-generation antimicrobials.

Publication Trends:
His recent publications demonstrate a consistent focus on optimizing anti-infective agents through structural modification, metabolic stabilization (e.g., deuteration), and targeted delivery strategies. The work spans mechanistic studies, bioconjugation techniques, and translational applications, reflecting a multidisciplinary approach to overcoming antibiotic resistance.

Scientific Awards:
• Outstanding Graduate of Peking Union Medical College (2009)
• Outstanding Master's Thesis, Soochow University (2008)

Advising and Grants:
While specific grant funding is not detailed in the text, Dr. Liu actively mentors prospective graduate students and collaborates extensively with senior researchers such as Professor Michael J. Miller. His role as Assistant Research Professor indicates leadership in ongoing research projects, likely supported by institutional and external funding. He contributes to training the next generation of medicinal chemists through hands-on research supervision.

Labs and Teams:
Dr. Liu is part of the research group led by Professor Michael J. Miller at the University of Notre Dame, a well-established team in antibiotic discovery and bioinorganic chemistry. This collaborative environment fosters innovation in drug design, leveraging expertise in synthesis, microbiology, and structural analysis.